Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine

被引:14
作者
Xuan, Shouyi [1 ]
Wu, Yanbin [2 ,3 ]
Chen, Xiaofang [2 ,3 ]
Liu, Jun [2 ,3 ]
Yan, Aixia [1 ]
机构
[1] Beijing Univ Chem Technol, Dept Pharmaceut Engn, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China
[2] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[3] Peking Union Med Coll, Beijing 100050, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV-1 integrase ST inhibitors (HIV-1 INSTIs); Quantitative structure-activity relationship (QSAR); Multilinear regression (MLR); Support vector machine (SVM); Kohonen's self-organizing map (SOM); VIRUS TYPE-1 INTEGRASE; STRAND-TRANSFER; 4,5-DIHYDROXYPYRIMIDINE CARBOXAMIDES; BIOLOGICAL EVALUATION; CATALYTIC DOMAIN; ACID; DESIGN; POTENT; DISCOVERY; PHARMACOPHORE;
D O I
10.1016/j.bmcl.2013.01.081
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study, four computational quantitative structure-activity relationship models were built to predict the biological activity of HIV-1 integrase strand transfer (ST) inhibitors. 551 Inhibitors whose bio-activities were detected by radiolabeling method were collected. The molecules were represented with 20 selected MOE descriptors. All inhibitors were divided into a training set and a test set with two methods: (1) by a Kohonen's self-organizing map (SOM); (2) by a random selection. For every training set and test set, a multilinear regression (MLR) analysis and a support vector machine (SVM) were used to establish models, respectively. For the test set divided by SOM, the correlation coefficients (rs) were over 0.91, and for the test set split randomly, the rs were over 0.86. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1648 / 1655
页数:8
相关论文
共 73 条
[1]  
[Anonymous], 2012, LIBSVM LIB SUPPORT V
[2]  
[Anonymous], MACCS KEYS
[3]  
[Anonymous], CORINA
[4]  
[Anonymous], MOE MOL OP ENV VERS
[5]   HIV-1 integrase: Structural organization, conformational changes, and catalysis [J].
Asante-Appiah, E ;
Skalka, AM .
ADVANCES IN VIRUS RESEARCH, VOL 52, 1999, 52 :351-369
[6]   QSAR analysis of some phthalimide analogues based inhibitors of HIV-1 integrase [J].
Bansal, Ruchi ;
Karthikeyan, C. ;
Moorthy, N. S. Hari Narayana ;
Trivedi, Piyush .
ARKIVOC, 2007, :66-81
[7]   Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors [J].
Barreca, ML ;
Ferro, S ;
Rao, A ;
De Luca, L ;
Zappalà, M ;
Monforte, AM ;
Debyser, Z ;
Witvrouw, M ;
Chimirri, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) :7084-7088
[8]   Linker-modified quinoline derivatives targeting HIV-1 integrase:: synthesis and biological activity [J].
Bernard, C ;
Zouhiri, F ;
Normand-Bayle, M ;
Danet, M ;
Desmaële, D ;
Leh, H ;
Mouscadet, JF ;
Mbemba, G ;
Thomas, CM ;
Bonnenfant, S ;
Le Bret, M ;
d'Angelo, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) :2473-2476
[9]   Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones [J].
Boros, Eric E. ;
Johns, Brian A. ;
Garvey, Edward P. ;
Koble, Cecilia S. ;
Miller, Wayne H. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) :5668-5672
[10]   QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors [J].
Cheng, Zhengjun ;
Zhang, Yuntao ;
Fu, Weizhong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) :3970-3980